A mutant of tissue factor pathway inhibitor, dna sequence and use for detecting thrombotic disorders
CA 2340460 A1 · Owner: Prohaska, Wolfgang · Inventors: Prohaska, Wolfgang; Goetting, Christian; Kleesiek, Knut
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to a novel mutant of tissue factor pathway inhibitor (TFPI) protein and its corresponding DNA sequence. The mutant can be found in humans who show or may show an increased risk of thrombotic diseases. By screening samples of human blood for said DNA or fragments of it it is , possible to predict a disposition of thrombotic disorders by which prophylactic application or measures can be initiated.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 18, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 18, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 18, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.